NCT00003270View on ClinicalTrials.gov

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 4, 1997

Primary Completion Date

October 16, 2017

Study Completion Date

October 16, 2017

Conditions
Graft Versus Host DiseaseLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
Interventions
BIOLOGICAL

anti-thymocyte globulin

IV

BIOLOGICAL

filgrastim

IV

DRUG

busulfan

IV

DRUG

cyclophosphamide

IV

DRUG

cyclosporine

IV

DRUG

methylprednisolone

IV

PROCEDURE

bone marrow ablation with stem cell support

IV

PROCEDURE

umbilical cord blood transplantation

IV

RADIATION

radiation therapy

High energy X-rays

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00003270 - Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter